Pinnacle Associates’s Amgen AMGN Stock Holding History

Pinnacle Associates’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.8M	Sell	62,004 -1,113	-2%	-$397K	0.28%	86
2025 Q4	$20.7M	Buy	63,117 +434	+0.7%	+$138K	0.27%	90
2025 Q3	$17.7M	Buy	62,683 +2,556	+4%	+$741K	0.23%	102
2025 Q2	$16.8M	Buy	60,127 +1,608	+3%	+$456K	0.24%	95
2025 Q1	$18.2M	Buy	58,519 +49	+0.1%	+$14.5K	0.27%	89
2024 Q4	$15.2M	Buy	58,470 +1,915	+3%	+$568K	0.21%	102
2024 Q3	$16.3M	Sell	56,555 -3,296	-6%	-$1.08M	0.28%	99
2024 Q2	$18.7M	Sell	59,851 -3,627	-6%	-$1.07M	0.29%	91
2024 Q1	$18M	Buy	63,478 +6,923	+12%	+$2.03M	0.28%	92
2023 Q4	$16.3M	Sell	56,555 -605	-1%	-$165K	0.27%	100
2023 Q3	$15.4M	Sell	57,160 -4,489	-7%	-$1.12M	0.29%	101
2023 Q2	$13.7M	Buy	61,649 +1,882	+3%	+$437K	0.24%	115
2023 Q1	$14.4M	Buy	59,767 +5,243	+10%	+$1.29M	0.3%	103
2022 Q4	$14.3M	Sell	54,524 -5,397	-9%	-$1.45M	0.31%	93
2022 Q3	$13.5M	Sell	59,921 -822	-1%	-$199K	0.31%	97
2022 Q2	$14.8M	Sell	60,743 -1,434	-2%	-$351K	0.32%	93
2022 Q1	$15M	Buy	62,177 +488	+0.8%	+$112K	0.27%	112
2021 Q4	$13.9M	Sell	61,689 -1,333	-2%	-$281K	0.24%	125
2021 Q3	$13.4M	Sell	63,022 -2,555	-4%	-$588K	0.25%	115
2021 Q2	$16M	Buy	65,577 +1,042	+2%	+$256K	0.29%	103
2021 Q1	$16.1M	Buy	64,535 +385	+0.6%	+$91.9K	0.31%	95
2020 Q4	$14.7M	Sell	64,150 -6,181	-9%	-$1.43M	0.3%	96
2020 Q3	$17.9M	Sell	70,331 -221	-0.3%	-$54.8K	0.42%	65
2020 Q2	$16.6M	Buy	70,552 +994	+1%	+$227K	0.41%	68
2020 Q1	$14.1M	Buy	69,558 +891	+1%	+$195K	0.43%	68
2019 Q4	$16.6M	Sell	68,667 -5,775	-8%	-$1.27M	0.36%	80
2019 Q3	$14.4M	Buy	74,442 +3,237	+5%	+$621K	0.34%	80
2019 Q2	$13.1M	Buy	71,205 +3,738	+6%	+$669K	0.31%	88
2019 Q1	$12.8M	Sell	67,467 -3,516	-5%	-$671K	0.29%	96
2018 Q4	$13.8M	Buy	70,983 +1,664	+2%	+$325K	0.36%	79
2018 Q3	$14.4M	Sell	69,319 -461	-0.7%	-$90.9K	0.3%	93
2018 Q2	$12.9M	Sell	69,780 -1,907	-3%	-$337K	0.27%	107
2018 Q1	$12.2M	Sell	71,687 -2,376	-3%	-$436K	0.24%	113
2017 Q4	$12.9M	Sell	74,063 -1,713	-2%	-$303K	0.25%	102
2017 Q3	$14.1M	Sell	75,776 -1,715	-2%	-$304K	0.26%	103
2017 Q2	$13.3M	Sell	77,491 -2,274	-3%	-$370K	0.26%	103
2017 Q1	$13.1M	Sell	79,765 -210	-0.3%	-$34.9K	0.25%	107
2016 Q4	$11.7M	Sell	79,975 -349	-0.4%	-$52.5K	0.24%	113
2016 Q3	$13.4M	Sell	80,324 -1,876	-2%	-$317K	0.27%	101
2016 Q2	$12.5M	Sell	82,200 -833	-1%	-$130K	0.27%	102
2016 Q1	$12.4M	Sell	83,033 -397	-0.5%	-$59K	0.27%	105
2015 Q4	$13.5M	Sell	83,430 -1,614	-2%	-$254K	0.28%	98
2015 Q3	$11.8M	Sell	85,044 -1,697	-2%	-$267K	0.26%	95
2015 Q2	$13.3M	Buy	86,741 +3,230	+4%	+$517K	0.25%	102
2015 Q1	$13.3M	Buy	83,511 +2,732	+3%	+$430K	0.25%	97
2014 Q4	$12.9M	Sell	80,779 -51	-0.1%	-$7.95K	0.25%	101
2014 Q3	$11.4M	Sell	80,830 -1,058	-1%	-$138K	0.23%	111
2014 Q2	$9.69M	Buy	81,888 +4,588	+6%	+$531K	0.19%	127
2014 Q1	$9.53M	Sell	77,300 -9,000	-10%	-$1.09M	0.19%	119
2013 Q4	$9.85M	Sell	86,300 -1,942	-2%	-$221K	0.19%	118
2013 Q3	$9.88M	Sell	88,242 -2,126	-2%	-$231K	0.2%	113
2013 Q2	$8.92M	Buy	+90,368	New	+$9.38M	0.2%	120

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pinnacle Associates's AMGN Position: Q1 2026 in Review

Pinnacle Associates reduced its Amgen (AMGN) stake by 1.8% in Q1 2026, selling an estimated $397K and leaving 62,004 shares worth $21.8M. The position accounts for 0.28% of the portfolio, ranked #86.

Pinnacle Associates first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Pinnacle Associates held 62,004 shares of Amgen worth $21.8M as of Q1 2026.
Pinnacle Associates sold 1,113 Amgen shares in Q1 2026, an estimated $397K.
Amgen made up 0.28% of Pinnacle Associates's portfolio in Q1 2026, its #86 holding.
Pinnacle Associates first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.